India biggest producer of 'game-changer' hydroxychloroquine drug; has enough capacity
NEW DELHI: India is the biggest manufacturer of hydroxychloroquine, the anti-malarial drug that is being touted as 'game-changer' in the fight against COVID-19 and is being aggressively sought by US President Donald Trump.
The country has the capacity to quickly ramp up the output of hydroxychloroquine.
Days after it added the drug to the list of more than two dozen APIs that cannot be exported while officials get a handle on how much will be needed for COVID-19 outbreak in the country, India on Tuesday agreed to lift the ban after Trump sought supplies for the US.
India manufactures 70 per cent of the world's supply of hydroxychloroquine, according to Indian Pharmaceutical Alliance (IPA) secretary-general Sudarshan Jain.
The country has a production capacity of 40 tonnes of hydroxychloroquine (HCQ) every month, implying 20 crore tablets of 200 mg each. And since the drug is also used to auto-immune diseases like rheumatoid arthritis and lupus, manufacturers have good production capacities that can also be ramped up.
Ipca Laboratories, Zydus Cadila and Wallace Pharmaceuticals are top pharma companies manufacturing HCQ in India.
Jain says the production capacity is sufficient to meet the current demand and if the need arises, the companies are committed to ramping up production.
Recently, the ministry of health and family welfare had reportedly placed an order for around 10 crore tables of HCQ with Ipca laboratories and Zydus Cadila.
The drug is not manufactured in developed nations such as the US because of non-existent malaria.
Hydroxychloroquine is very similar to chloroquine, one of the oldest and best-known anti-malarial drugs, but with lesser side-effects. It can be bought over the counter and fairly inexpensive.
But its purchase and use has been severely restricted as it was selectively used in the treatment of coronavirus because of its anti-viral properties.
India gets the active pharmaceutical ingredient (API) that is used to manufacture HCQ from China and supplies so far have been steady.
As much as 70 per cent of all the APIs needed by India to manufacture drugs come from China.
After Trump stated that the US could "retaliate" if India does not release stocks of the drug, Indian officials said exports of hydroxychloroquine and paracetamol will be allowed depending on availability of stock after meeting domestic requirements and existing orders.
译文来源：三泰虎 http://www.santaihu.com/49663.html 译者：Jessica.Wu
ivanshika reddy kandakatla
Because of the corrupt congress medical industry didnt grow in india.now with modiji taking care we are showing the world a way.jai hind
It's high time we produce the raw material also, China is cheat better not depend on them
Surplus stock can certainly be sent to the needy countries. The manufacturers may also go for more production to the meet the need abroad after ensuring sufficient stock for local use. This will help these companies to run their business and engage the idle work force by ensuring proper safety measures for them. India will also earn some much valued dollars at this critical juncture.
US sells cardiac shunt at exorbitant price.
Indian medicines are avaliable in the US at 10 times the price as that sold in India.
How do you know??? That could be due to the DOLLAR being way higher than the RUPEE
Prudent policy : have enough for home, spare excess for outsiders !
Chinese loop is quite inescapable. Since API is imported from China, we must make efforts not to depend upon China. Let us be self reliant.
Proud moment for Indian Pharma companies.
India will play a leading role....we will be the game changer....good for the country and economy....
Ramesh Chandra Padhy
US should have asked for India's help with more friendly manner and should have announced financial aid in lieu of supply of the life saving drugs. US is a developed country and should come forward to the rescue of India's economy.
The country showing itself as a super country in films is on its knees… All super heroes (Iron Man, Superman, Black Panther, Wonder Woman) are locked indoors for fear of Corona...
Trump said US could 'retaliate' if India doesn't comply to export the anti viral drug !!
It is not a request for the much needed drug but a threatening voice from Modi's so called buddy. And how easily boasting India conceded.
Trump is in desperation..with elections in less than an year..
After Trump's retaliation threat India's Hanji we will export the medicine to u. Isn't it actually we proved ourselves spine less country?
India is country with heart so India will help all friends during their hour of crisis unlike China which is doing God knows what?
We have ordered 2 00,000 ventilators on Chiana.
Trump should be advised not to threaten or blackmail India. India has Mr Modi as the PM and not the dummy MMS(mankind’s most Shameless)
I wish Modi thinks to replace China in production of raw materials, electronics, and various product which China has monopoly off. Entire world will be happy to trade with India than China. I pledge not to actively buy Chinese companies product e.g. Mi phone etc.
HCQ is not cure nor it can prevent Covid-19. It's just one of the options to combat like many other medicines. Just because Trump has obsession with HCQ, he simply showing off domastic subjects that he is doing everything to get cure.
The congress is trying to make a mountain of a mole hill on export of HCQ API medicines; the requirement of USA need to be fulfilled because USA is worst affected by nCOVID 19 and secondly US is home to millions of Indians
Indian medicine will cure the world of C-e virus.
India shall supply to the needy nations after meeting our own demands.
India should help USA, considering humanity and long relationship
US PRESIDENT ONE PHONE CALL MADE 56 INCH CHEST BOWED BEFORE UNCLE SAM
it's a opportunity for india to take export advantage like china supplying mask and ventilators to COVID-19 affected countries